DM
ADMA icon

Deerfield Management’s ADMA Biologics ADMA Stock Holding History

Deerfield Management’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-47,016
Closed -$940K – 118
2024
Q3 		$940K Sell
47,016
-12,204
-21% -$190K 0.01% 153
2024
Q2 		$662K Sell
59,220
-21,984
-27% -$184K 0.01% 209
2024
Q1 		$536K Buy
81,204
+38,547
+90% +$211K 0.01% 127
2023
Q4 		$193K Buy
+42,657
New +$158K ﹤0.01% 180

Other funds holding ADMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Deerfield Management's ADMA Position: Q4 2024 in Review

Deerfield Management sold out of ADMA Biologics (ADMA) in Q4 2024, closing a stake of 47,016 shares — an estimated $940K sold.

Deerfield Management first reported a position in ADMA in Q4 2023 and held it in 4 quarters. The position peaked at $940K in Q3 2024. 322 funds tracked by Wall St. Rank hold ADMA as of Q4 2024.

  • Deerfield Management reported no remaining ADMA Biologics position as of Q4 2024 after selling out during the quarter.
  • Deerfield Management sold 47,016 ADMA Biologics shares in Q4 2024, an estimated $940K.
  • Deerfield Management first reported a position in ADMA Biologics in Q4 2023 and held it in 4 quarters.
  • Deerfield Management's ADMA Biologics position peaked at $940K in Q3 2024.
  • 322 funds tracked by Wall St. Rank held ADMA Biologics as of Q4 2024.

Based on Deerfield Management's 13F filing for Q4 2024, filed 14 Feb 2025.